| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
American Journal of Epidemiology Vol. 134, No. 11: 1266-1277
Copyright © 1991 by The Johns Hopkins University School of Hygiene and Public Health
research-article |
The Relation between Serum Albumin Levels and Risk of Coronary Heart Disease in the Multiple Risk Factor Intervention Trial
1Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh Pittsburgh, PA
2MRFTT Coordinating Center, Department of Biostatistics Minneapolis, MN
3Department of Pathology, University of Vermont Medical School Burlington, VT
Reprint requests to Dr. Lewis H. Kuller, University of Pittsburgh, Graduate School of Public Health, 130 DeSoto Street, Pittsburgh, PA 15261
The relation between serum albumin levels and subsequent incidence of myocardial infarction and coronary heart disease deaths was evaluated using stored serum from the Multiple Risk Factor intervention Trial (MRFIT). There were 91 coronary heart disease deaths, 113 myocardial infarction patients, and 405 controls matched to cases within 5 years of age, treatment group, and clinic site. There was a highly significant inverse relation between serum albumin level and risk of coronary heart disease. Individuals with a baseline level of serum albumin
4.7 g/dl had an odds ratio of 0.45 as compared with individuals with a baseline level of serum albumin <4.4 g/dl. The relation persisted after adjusting for other cardiovascular risk factors (blood pressure, smoking, and serum cholesterol). The association was stronger for coronary heart disease deaths than for surviving myocardial infarction patients, and for cigarette smokers as compared with cigarette nonsmokers. The deaths studied occurred in the time period at least 6 years after the sara had been obtained and up to 10.5 years of follow-up, and the myocardial infarctions studied occurred within the first 6.5 years of follow-up. There was no consistent relation between time and death due to coronary heart disease or myocardial infarction and albumin levels. Albumin levels are related to the acute phase reaction. Lower albumin levels may be a marker of persistent injury to arteries and progression of atherosclerosis and thrombosis. The consistent relation between albumin and coronary heart disease risk requires further evaluation.
albumins; C-reactive protein; coronary disease; smoking
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
A. M. Kucharska-Newton, D. J. Couper, J. S. Pankow, R. J. Prineas, T. D. Rea, N. Sotoodehnia, A. Chakravarti, A. R. Folsom, D. S. Siscovick, and W. D. Rosamond Hemostasis, Inflammation, and Fatal and Nonfatal Coronary Heart Disease: Long-Term Follow-Up of the Atherosclerosis Risk in Communities (ARIC) Cohort Arterioscler Thromb Vasc Biol, December 1, 2009; 29(12): 2182 - 2190. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. W. M. Schalk, M. Visser, M. A. Bremmer, B. W. J. H. Penninx, L. M. Bouter, and D. J. H. Deeg Change of Serum Albumin and Risk of Cardiovascular Disease and All-Cause Mortality: Longitudinal Aging Study Amsterdam Am. J. Epidemiol., November 15, 2006; 164(10): 969 - 977. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Frohlich, M. Sund, H. Lowel, A. Imhof, A. Hoffmeister, and W. Koenig Independent association of various smoking characteristics with markers of systemic inflammation in men: Results from a representative sample of the general population (MONICA Augsburg Survey 1994/95) Eur. Heart J., July 2, 2003; 24(14): 1365 - 1372. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.-j. Zhang and B. Frei A different view on human albumin--authors' reply Cardiovasc Res, June 1, 2003; 58(3): 723 - 724. [Full Text] [PDF] |
||||
![]() |
J. D. Curb, R. D. Abbott, B. L. Rodriguez, P. Sakkinen, J. S. Popper, K. Yano, and R. P. Tracy C-Reactive Protein and the Future Risk of Thromboembolic Stroke in Healthy Men Circulation, April 22, 2003; 107(15): 2016 - 2020. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Talbot, J. D. del Rio, and P. D. Weinberg Effect of fluid mechanical stresses and plasma constituents on aggregation of LDL J. Lipid Res., April 1, 2003; 44(4): 837 - 845. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Djousse, K. J. Rothman, L. A. Cupples, D. K. Arnett, and R. C. Ellison Relation Between Serum Albumin and Carotid Atherosclerosis: The NHLBI Family Heart Study Stroke, January 1, 2003; 34(1): 53 - 57. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Djousse, K. J. Rothman, L. A. Cupples, D. Levy, and R. C. Ellison Serum Albumin and Risk of Myocardial Infarction and All-Cause Mortality in the Framingham Offspring Study Circulation, December 3, 2002; 106(23): 2919 - 2924. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Delgado-Rodriguez, M. Medina-Cuadros, A. Gomez-Ortega, G. Martinez-Gallego, M. Mariscal-Ortiz, M. A. Martinez-Gonzalez, and M. Sillero-Arenas Cholesterol and Serum Albumin Levels as Predictors of Cross Infection, Death, and Length of Hospital Stay Arch Surg, July 1, 2002; 137(7): 805 - 812. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. F. Geffken, M. Cushman, G. L. Burke, J. F. Polak, P. A. Sakkinen, and R. P. Tracy Association between Physical Activity and Markers of Inflammation in a Healthy Elderly Population Am. J. Epidemiol., February 1, 2001; 153(3): 242 - 250. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Castaneda, O. I Bermudez, and K. L Tucker Protein nutritional status and function are associated with type 2 diabetes in Hispanic elders Am. J. Clinical Nutrition, July 1, 2000; 72(1): 89 - 95. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. G. Christen, U. A. Ajani, R. J. Glynn, and C. H. Hennekens Blood Levels of Homocysteine and Increased Risks of Cardiovascular Disease: Causal or Casual? Arch Intern Med, February 28, 2000; 160(4): 422 - 434. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Kristal-Boneh, H. Silber, G. Harari, and P. Froom The association of resting heart rate with cardiovascular, cancer and all-cause mortality. Eight year follow-up of 3527 male Israeli employees (the CORDIS Study) Eur. Heart J., January 2, 2000; 21(2): 116 - 124. [Abstract] [PDF] |
||||
![]() |
R. Jorde, J. Sundsfjord, P. Fitzgerald, and K. H. Bonaa Serum Calcium and Cardiovascular Risk Factors and Diseases : The Tromso Study Hypertension, September 1, 1999; 34(3): 484 - 490. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. P. Tracy Inflammation in Cardiovascular Disease : Cart, Horse, or Both? Circulation, May 26, 1998; 97(20): 2000 - 2002. [Full Text] [PDF] |
||||
![]() |
J. Danesh, R. Collins, P. Appleby, and R. Peto Association of Fibrinogen, C-reactive Protein, Albumin, or Leukocyte Count With Coronary Heart Disease: Meta-analyses of Prospective Studies JAMA, May 13, 1998; 279(18): 1477 - 1482. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. W. Evans, B. J. Shaten, J. D. Hempel, J. A. Cutler, and L. H. Kuller Homocyst(e)ine and Risk of Cardiovascular Disease in the Multiple Risk Factor Intervention Trial Arterioscler Thromb Vasc Biol, October 1, 1997; 17(10): 1947 - 1953. [Abstract] [Full Text] |
||||
![]() |
W. M. Tierney, M. D. Murray, D. L. Gaskins, and X.-H. Zhou Using Computer-based Medical Records to Predict Mortality Risk for Inner-city Patients with Reactive Airways Disease J. Am. Med. Inform. Assoc., July 1, 1997; 4(4): 313 - 321. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. P. Tracy, R. N. Lemaitre, B. M. Psaty, D. G. Ives, R. W. Evans, M. Cushman, E. N. Meilahn, and L. H. Kuller Relationship of C-Reactive Protein to Risk of Cardiovascular Disease in the Elderly: Results From the Cardiovascular Health Study and the Rural Health Promotion Project Arterioscler Thromb Vasc Biol, June 1, 1997; 17(6): 1121 - 1127. [Abstract] [Full Text] |
||||
![]() |
E. M. Macy, T. E. Hayes, and R. P. Tracy Variability in the measurement of C-reactive protein in healthy subjects: implications for reference intervals and epidemiological applications Clin. Chem., January 1, 1997; 43(1): 52 - 58. [Abstract] [Full Text] [PDF] |
||||
![]() |
L.H. Kuller, L. Shemanski, B.M. Psaty, N.O. Borhani, J. Gardin, M.N. Haan, D.H. O'Leary, P.J. Savage, G.S. Tell, and R. Tracy Subclinical Disease as an Independent Risk Factor for Cardiovascular Disease Circulation, August 15, 1995; 92(4): 720 - 726. [Abstract] [Full Text] |
||||
![]() |
M.-C. Corti, J. M. Guralnik, M. E. Salive, and J. D. Sorkin Serum Albumin Level and Physical Disability as Predictors of Mortality in Older Persons JAMA, October 5, 1994; 272(13): 1036 - 1042. [Abstract] [PDF] |
||||













